268 related articles for article (PubMed ID: 25806972)
1. ARID5B, IKZF1 and non-genetic factors in the etiology of childhood acute lymphoblastic leukemia: the ESCALE study.
Rudant J; Orsi L; Bonaventure A; Goujon-Bellec S; Baruchel A; Petit A; Bertrand Y; Nelken B; Pasquet M; Michel G; Saumet L; Chastagner P; Ducassou S; Réguerre Y; Hémon D; Clavel J
PLoS One; 2015; 10(3):e0121348. PubMed ID: 25806972
[TBL] [Abstract][Full Text] [Related]
2. High-resolution melting analyses for genetic variants in ARID5B and IKZF1 with childhood acute lymphoblastic leukemia susceptibility loci in Taiwan.
Lin CY; Li MJ; Chang JG; Liu SC; Weng T; Wu KH; Yang SF; Huang FK; Lo WY; Peng CT
Blood Cells Mol Dis; 2014; 52(2-3):140-5. PubMed ID: 24200646
[TBL] [Abstract][Full Text] [Related]
3. Association of Genetic Variants in ARID5B, IKZF1 and CEBPE with Risk of Childhood de novo B-Lineage Acute Lymphoblastic Leukemia in India.
Bhandari P; Ahmad F; Mandava S; Das BR
Asian Pac J Cancer Prev; 2016; 17(8):3989-95. PubMed ID: 27644650
[TBL] [Abstract][Full Text] [Related]
4. Association of genetic variation in IKZF1, ARID5B, and CEBPE and surrogates for early-life infections with the risk of acute lymphoblastic leukemia in Hispanic children.
Hsu LI; Chokkalingam AP; Briggs FB; Walsh K; Crouse V; Fu C; Metayer C; Wiemels JL; Barcellos LF; Buffler PA
Cancer Causes Control; 2015 Apr; 26(4):609-19. PubMed ID: 25761407
[TBL] [Abstract][Full Text] [Related]
5. Association of genetic variation in IKZF1, ARID5B, CDKN2A, and CEBPE with the risk of acute lymphoblastic leukemia in Tunisian children and their contribution to racial differences in leukemia incidence.
Gharbi H; Ben Hassine I; Soltani I; Safra I; Ouerhani S; Bel Haj Othmen H; Teber M; Farah A; Amouri H; Toumi NH; Abdennebi S; Abbes S; Menif S
Pediatr Hematol Oncol; 2016 Apr; 33(3):157-67. PubMed ID: 27184773
[TBL] [Abstract][Full Text] [Related]
6. Association of ARID5B and IKZF1 Variants with Leukemia from Northern India.
Bhat A; Shah R; Bhat GR; Verma S; Sharma V; Sharma I; Pandita M; Bakshi D; Sharma B; Suri J; Kumar R
Genet Test Mol Biomarkers; 2019 Mar; 23(3):176-179. PubMed ID: 30810385
[TBL] [Abstract][Full Text] [Related]
7.
Al-Zayan NR; Ashour MJ; Abuwarda HN; Sharif FA
Pediatr Hematol Oncol; 2024; 41(2):103-113. PubMed ID: 37578068
[TBL] [Abstract][Full Text] [Related]
8. Contributions of IKZF1, DDC, CDKN2A, CEBPE, and LMO1 Gene Polymorphisms to Acute Lymphoblastic Leukemia in a Yemeni Population.
Al-Absi B; Razif MFM; Noor SM; Saif-Ali R; Aqlan M; Salem SD; Ahmed RH; Muniandy S
Genet Test Mol Biomarkers; 2017 Oct; 21(10):592-599. PubMed ID: 28768142
[TBL] [Abstract][Full Text] [Related]
9. Association of three polymorphisms in ARID5B, IKZF1 and CEBPE with the risk of childhood acute lymphoblastic leukemia in a Chinese population.
Wang Y; Chen J; Li J; Deng J; Rui Y; Lu Q; Wang M; Tong N; Zhang Z; Fang Y
Gene; 2013 Jul; 524(2):203-7. PubMed ID: 23608171
[TBL] [Abstract][Full Text] [Related]
10. ARID5B and IKZF1 variants, selected demographic factors, and childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group.
Linabery AM; Blommer CN; Spector LG; Davies SM; Robison LL; Ross JA
Leuk Res; 2013 Aug; 37(8):936-42. PubMed ID: 23692655
[TBL] [Abstract][Full Text] [Related]
11. Confirmation of childhood acute lymphoblastic leukemia variants, ARID5B and IKZF1, and interaction with parental environmental exposures.
Evans TJ; Milne E; Anderson D; de Klerk NH; Jamieson SE; Talseth-Palmer BA; Bowden NA; Holliday EG; Rudant J; Orsi L; Richardson E; Lavis L; Catchpoole D; Attia JR; Armstrong BK; Clavel J; Scott RJ
PLoS One; 2014; 9(10):e110255. PubMed ID: 25310577
[TBL] [Abstract][Full Text] [Related]
12. Novel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populations.
Xu H; Yang W; Perez-Andreu V; Devidas M; Fan Y; Cheng C; Pei D; Scheet P; Burchard EG; Eng C; Huntsman S; Torgerson DG; Dean M; Winick NJ; Martin PL; Camitta BM; Bowman WP; Willman CL; Carroll WL; Mullighan CG; Bhojwani D; Hunger SP; Pui CH; Evans WE; Relling MV; Loh ML; Yang JJ
J Natl Cancer Inst; 2013 May; 105(10):733-42. PubMed ID: 23512250
[TBL] [Abstract][Full Text] [Related]
13. Contributions of ARID5B, IKZF1, PIP4K2A, and GATA3 Gene Polymorphisms to Childhood Acute Lymphoblastic Leukemia in a Chinese Population.
Liu X; Xiao M; Xing Z; Jiang H; Zhu C; Zhang X; Li W; Wang Z; Wu F; Chen Y
J Pediatr Hematol Oncol; 2023 Apr; 45(3):123-129. PubMed ID: 36952466
[TBL] [Abstract][Full Text] [Related]
14. IKZF1 gene polymorphisms increased the risk of childhood acute lymphoblastic leukemia in an Iranian population.
Bahari G; Hashemi M; Naderi M; Taheri M
Tumour Biol; 2016 Jul; 37(7):9579-86. PubMed ID: 26790447
[TBL] [Abstract][Full Text] [Related]
15.
Lopes BA; Barbosa TC; Souza BKS; Poubel CP; Pombo-de-Oliveira MS; Emerenciano M;
Cancer Prev Res (Phila); 2017 Dec; 10(12):738-744. PubMed ID: 28947432
[TBL] [Abstract][Full Text] [Related]
16. Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia.
Papaemmanuil E; Hosking FJ; Vijayakrishnan J; Price A; Olver B; Sheridan E; Kinsey SE; Lightfoot T; Roman E; Irving JA; Allan JM; Tomlinson IP; Taylor M; Greaves M; Houlston RS
Nat Genet; 2009 Sep; 41(9):1006-10. PubMed ID: 19684604
[TBL] [Abstract][Full Text] [Related]
17. The Genetic Variants of IKZF1 Gene Linked with the Growing Risk of Childhood Acute Lymphoblastic Leukaemia.
Tayel SI; El-Hefnway SM; Abo El-Fotoh WMM; El-Zayat RS
Curr Mol Med; 2019; 19(1):32-39. PubMed ID: 30806315
[TBL] [Abstract][Full Text] [Related]
18. Childhood acute lymphoblastic leukemia-associated risk-loci IKZF1, ARID5B and CEBPE and risk of pediatric non-Hodgkin lymphoma: a report from the Berlin-Frankfurt-Münster Study Group.
Bartram T; Burkhardt B; Wössmann W; Seidemann K; Zimmermann M; Cario G; Lisfeld J; Ellinghaus E; Franke A; Houlston RS; Schrappe M; Reiter A; Stanulla M
Leuk Lymphoma; 2015 Mar; 56(3):814-6. PubMed ID: 25005032
[No Abstract] [Full Text] [Related]
19. Are ARID5B and IKZF1 polymorphisms also associated with childhood acute myeloblastic leukemia: the ESCALE study (SFCE)?
Rudant J; Orsi L; Bonaventure A; Goujon-Bellec S; Corda E; Baruchel A; Bertrand Y; Nelken B; Robert A; Michel G; Sirvent N; Chastagner P; Ducassou S; Rialland X; Hémon D; Leverger G; Clavel J
Leukemia; 2013 Mar; 27(3):746-8. PubMed ID: 22922568
[No Abstract] [Full Text] [Related]
20. Enhancer polymorphisms at the IKZF1 susceptibility locus for acute lymphoblastic leukemia impact B-cell proliferation and differentiation in both Down syndrome and non-Down syndrome genetic backgrounds.
Gant VU; Junco JJ; Terrell M; Rashid R; Rabin KR
PLoS One; 2021; 16(1):e0244863. PubMed ID: 33411777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]